The Ensign Group (ENSG)
(Delayed Data from NSDQ)
$148.43 USD
-0.61 (-0.41%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $148.38 -0.05 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$148.43 USD
-0.61 (-0.41%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $148.38 -0.05 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum B VGM
Zacks News
Ensign Group (ENSG) Q4 Earnings Match Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q4 results reflect higher revenues, partly offset by steep expenses.
Molina Healthcare (MOH) Q4 Earnings Beat on Higher Premiums
by Zacks Equity Research
Molina Healthcare (MOH) expects its 2022 business to witness reduced impacts from COVID. Strong Medicare and Medicaid performance is set to buoy results.
Ensign Group (ENSG) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 1.04% and 0.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio
by Zacks Equity Research
Mednax (MD) purchases Night Lite Pediatrics, LLC in Orlando to enhance its pediatric business line.
Ensign Group (ENSG) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Ensign Group (ENSG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Ensign Group (ENSG) Buys Facilities to Expand in California
by Zacks Equity Research
Ensign Group (ENSG) further expands in California by purchasing the operations of Arrowhead Springs Healthcare, San Bernardino, CL and Desert Mountain Care Center, Indio, CL.
Here is Why Growth Investors Should Buy Ensign Group (ENSG) Now
by Zacks Equity Research
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
Humana (HUM) Q4 Earnings Beat Estimates on Membership Growth
by Zacks Equity Research
Humana (HUM) is taking multiple initiatives like cost savings and others to generate $1 billion additional value to fund the Medicare Advantage business and boost Healthcare Services capabilities.
Ensign Group (ENSG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) to Spin Off Home Health & Hospice Unit
by Zacks Equity Research
Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.
Ensign Group (ENSG) Up 7.4% in 3 Months: More Growth Ahead?
by Zacks Equity Research
Ensign Group (ENSG) is likely to keep growing on the back of Skilled services and impressive financial strength.
Ensign Group (ENSG) Buys Nursing Facility to Expand in Arizona
by Zacks Equity Research
Ensign Group (ENSG) acquires operations of Estrella Health and Rehabilitation Center in Arizona to grow its portfolio and boost U.S. presence.
Ensign Group (ENSG) Hikes Dividend to Share More Profits
by Zacks Equity Research
Ensign Group's (ENSG) dividend hike reflects its intention to enhance shareholders' value supported by its strong financial position.
Here's Why Investors Should Hold Onto Ensign Group (ENSG)
by Zacks Equity Research
Riding high on a solid portfolio and a rising top line, Ensign Group (ENSG) holds enough potential to reap benefits for investors.
Zacks Industry Outlook Highlights: The Ensign Group and Brookdale Senior Living
by Zacks Equity Research
Zacks Industry Outlook Highlights: The Ensign Group and Brookdale Senior Living
2 Nursing Home Stocks to Brave the Oversupplied Market Woes
by Kaibalya Pravo Dey
Rising costs of equipment and excessive supply pitting downward pressures on occupancy are concerns for the Zacks Medical-Nursing Home industry. However, ENSG and BKD are well-positioned to not only pull through but also grow higher.
Ensign Group (ENSG) Buys Facilities to Boost Real Estate Suite
by Zacks Equity Research
Ensign Group (ENSG) acquires five skilled nursing and assisted living facilities in three U.S. states. The move underscores ENSG's efforts to grow its real estate portfolio and boost U.S. presence.
Ensign Group (ENSG) Q3 Earnings Meet, '21 Earnings Guidance Up
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings gain from improved revenues, partly offset by steep expenses.
Ensign Group (ENSG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 1.11% and 1.26%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is ProShares Russell 2000 Dividend Growers ETF (SMDV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SMDV
Ensign Group (ENSG) Acquires to Expand in Texas & Idaho
by Zacks Equity Research
Ensign Group (ENSG) establishes dominance in the Texas and Idaho markets with further buyouts.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA Healthcare (HCA) to Acquire Facilities in Utah From Steward
by Zacks Equity Research
HCA Healthcare (HCA) to buy five Utah hospitals from Steward to expand its dominance in the region, and provide cost-effective and enhanced healthcare to patients.
Ensign Group (ENSG) Down 4.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.